Last Posted: Feb 21, 2019
- Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
Zhang Lei et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Feb - Cystic fibrosis - an example of personalized and precision medicine.
Skov Marianne et al. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2019 Feb - Mimicry and well known genetic friends: molecular diagnosis in an Iranian cohort of suspected Bartter syndrome and proposition of an algorithm for clinical differential diagnosis.
Najafi Maryam et al. Orphanet journal of rare diseases 2019 Feb 14(1) 41 - Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis.
Villella Valeria R et al. Minerva pediatrica 2019 Feb - Health economic modelling in Cystic Fibrosis: A systematic review.
Mohindru Bishal et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2019 Feb - Outrage as cystic fibrosis drug firm posts big profit
The Observer, February 10, 2019 - ‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
A Joseph, Stat News, February 4, 2019 - Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles.
Shaw Liam P et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Jan - Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
Wu Ann Chen et al. American journal of respiratory and critical care medicine 2018 Dec 198(12) e116-e136 - Comparison of two sweat test systems for the diagnosis of cystic fibrosis in newborns.
Rueegg Corina S et al. Pediatric pulmonology 2019 Jan
.png)
No hay comentarios:
Publicar un comentario